Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

ASICS Trading

稲畑産業

YELLOW HAT

TECHNO ASSOCIE

ADVAN

KURODA ELECTRIC

伊藤忠エネクス

INABA DENKI SANGYO

Tokyo Electron

WEDS

Wakita

OKAYA

YAMAZEN

SIIX

YOKOHAMA REITO

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Hitachi Zosen etc.

NIPPON COKE & ENGINEERING

メルコホールディングス

ROHM

日本セラミック etc.

Financial Indicator Details: メディパルホールディングス+NICHIDEN (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: メディパルホールディングス+NICHIDEN (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Net profit margin	0.66%
C/F margin	2.19%
ROA	1.40%
ROE	4.88%
Growth	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Capital adequacy	28.74%
Liquidity ratio	114.72%
C/F ratio current liabilities	1,449.38%
Quick ratio	88.25%
Stability	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Equity growth	7.77%
Sales growth	2.20%
Net profit growth	60.12%
Operating C/F growth	3,207.09%
Turnover	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Inventory turnover	18.81day
Receivables turnover	81.26day
Payable turnover	105.42day
Working capita turnover	-5.35day
Market Value growth	24.16%
Dividend Yield	1.56%
PER	17.44%
PBR	0.85%
PCFR	5.26%
PSR	0.11%

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Net profit margin	110.04%	2.63%
C/F margin	-	3.47%
ROA	4.67%	3.12%
ROE	5.73%	3.81%
Growth	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Capital adequacy	81.58%	81.95%
Liquidity ratio	168.03%	556.87%
C/F ratio current liabilities	-	320.43%
Quick ratio	118.66%	509.00%
Stability	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Equity growth	-0.42%	2.94%
Sales growth	8.19%	-5.12%
Net profit growth	99.57%	-7.88%
Operating C/F growth	0	38.00%
Turnover	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Inventory turnover	-	0.04day
Receivables turnover	1.13day	89.57day
Payable turnover	-	32.66day
Working capita turnover	1.13day	56.95day
Market Value growth	24.16%	3.82%
Dividend Yield	-	2.13%
PER	28.75%	17.39%
PBR	1.64%	0.66%
PCFR	-	13.18%
PSR	31.63%	0.45%

View the financial indicators, more.

Financial Indicator Details: メディパル HLDGS+NICHIDEN

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Profitability
Net profit margin	0.42%
C/F margin	-0.07%
ROA	0.91%
ROE	3.28%
Recurring margin	1.14%
EBIT margin	0.95%
EBITDA margin	1.41%
NOPAT margin	0.57%
Sales SG rates	92.99%
Sales SG&A rates	6.24%
Sales R&D expenses rates	-
Sales depreciation rates	0.46%
Capital expenditures net sales ratio	-0.52%
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Growth
Growth rate of cash	-14.05%
Equity growth	3.91%
Total assets growth	-0.79%
Sales growth	3.28%
Net profit growth	583.68%
Operating C/F growth	-104.01%
Recurring profit growth	37.83%
EBIT growth	185.84%
EBITDA growth	82.37%
NOPAT growth	185.84%
Operating expenses growth	-
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Stability
Capital adequacy	27.80%
Liquidity ratio	113.45%
C/F ratio current liabilities	-43,932.14%
Quick ratio	87.23%
Fixed ratio	54.05%
D/E ratio	12.08%
Loan to Value Ratio	3.36%
Business investment C/F ratio	732.44%
Liabilities with interest growth	0.05%
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Turnover
Cash turnover	17.55day
Receivables turnover	83.55day
Inventory turnover	18.62day
Fixed assets turnover	25.42day
Total asset turnover	169.13day
Payable turnover	105.93day
Capital turnover	2.97day
Equity turnover	47.02day
Working capita turnover	-3.75day
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Balance sheet
Cash etc.	¥ 137 B
Accounts receivable-trade	¥ 571 B
Other Current Assets	¥ 772 B
Current Assets	¥ 909 B
Tangible Assets	¥ 184 B
Intangible Assets	¥ 9 B
Investment etc.	¥ 62 B
Total Assets	¥ 1.1 T
Current Liabilities	¥ 798 B
Fixed Liabilities	¥ 37 B
Liabilities with interest	¥ 46 B
Net Assets	¥ 330 B
Capital stock	¥ 22 B
Capital surplus etc.	¥ 308 B
Liabilities and net assets	¥ 1.1 T
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Income statement
Sales	¥ 2.5 T
Cost of Sales	¥ 2.3 T
Gross profit	¥ 191 B
Other income	¥ 10 B
SG&A	¥ 172 B
Other expenses	¥ 27 B
Net income	¥ 1 B
Operating income	¥ 18 B
Ordinary Income	¥ 26 B
EBITDA	¥ 20 B
Income before income taxes	¥ 8 B
Depreciation	¥ 11 B
R&D expenses	-
Income taxes	¥ 6 B
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Cash flow statement
Operating CF	¥ 13 B
Investment CF	¥ -29 B
Financial CF	¥ 10 B
Foreign Exchange Effects	-
Net Change in Cash	¥ -5 B
Free CF	¥ -15 B
Capital expenditures	¥ -25 B
Cash dividends paid	¥ -3 B
Repayment loans	¥ -3 B
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Shareowners' equity
Issuance of new shares	-
Dividends from surplus	¥ -3 B
Net income	¥ 1 B
Purchase of treasury stock	¥ -5 B
Other Change in Stockholders Equity	¥ -185 M
Other Change in Net Assets	¥ 44 B
Net Change in Net Assets	¥ 36 B

Financial Indicator Details: メディパル HLDGS+NICHIDEN

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Profitability
Net profit margin	59.65%	2.71%
C/F margin	-	2.38%
ROA	2.34%	3.41%
ROE	2.86%	4.26%
Recurring margin	83.12%	4.94%
EBIT margin	64.98%	4.86%
EBITDA margin	66.33%	5.52%
NOPAT margin	38.99%	2.91%
Sales SG rates	27.08%	85.55%
Sales SG&A rates	24.88%	9.74%
Sales R&D expenses rates	-	-
Sales depreciation rates	1.34%	0.66%
Capital expenditures net sales ratio	-	-0.04%
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Growth
Growth rate of cash	-17.24%	1.92%
Equity growth	0.84%	3.43%
Total assets growth	-3.87%	3.42%
Sales growth	7.45%	6.38%
Net profit growth	136.26%	13.32%
Operating C/F growth	-	3,107.93%
Recurring profit growth	3.19%	16.34%
EBIT growth	140.64%	15.59%
EBITDA growth	141.84%	13.37%
NOPAT growth	140.64%	15.59%
Operating expenses growth	¥ 4 K	-
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Stability
Capital adequacy	82.03%	80.12%
Liquidity ratio	179.22%	485.08%
C/F ratio current liabilities	-	507.81%
Quick ratio	125.80%	434.82%
Fixed ratio	3.43%	17.29%
D/E ratio	-	-
Loan to Value Ratio	-	-
Business investment C/F ratio	-	-2.02%
Liabilities with interest growth	-	-
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Turnover
Cash turnover	1,802.04day	105.29day
Receivables turnover	-	87.04day
Inventory turnover	-	0.03day
Fixed assets turnover	261.35day	40.13day
Total asset turnover	9,280.43day	289.59day
Payable turnover	-	34.13day
Capital turnover	859.83day	23.13day
Equity turnover	7,612.75day	232.03day
Working capita turnover	-	52.93day
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Balance sheet
Cash etc.	¥ 44 B	¥ 23 B
Accounts receivable-trade	-	¥ 15 B
Other Current Assets	¥ 20 B	¥ 19 B
Current Assets	¥ 65 B	¥ 42 B
Tangible Assets	¥ 7 B	¥ 9 B
Intangible Assets	¥ 26 M	¥ 433 M
Investment etc.	¥ 182 B	¥ 8 B
Total Assets	¥ 254 B	¥ 61 B
Current Liabilities	¥ 35 B	¥ 7 B
Fixed Liabilities	¥ 5 B	¥ 2 B
Liabilities with interest	-	-
Net Assets	¥ 214 B	¥ 50 B
Capital stock	¥ 22 B	¥ 5 B
Capital surplus etc.	¥ 191 B	¥ 45 B
Liabilities and net assets	¥ 254 B	¥ 61 B
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Income statement
Sales	¥ 805 B	¥ 58 B
Cost of Sales	¥ 805 B	¥ 50 B
Gross profit	¥ 62 M	¥ 8 B
Other income	¥ 5 B	¥ 457 M
SG&A	¥ 12 B	¥ 7 B
Other expenses	¥ 4 B	¥ 1 B
Net income	¥ 5 B	¥ 556 M
Operating income	¥ 3 B	¥ 1 B
Ordinary Income	¥ 8 B	¥ 1 B
EBITDA	¥ 7 B	¥ 1 B
Income before income taxes	¥ 5 B	¥ 1 B
Depreciation	¥ 1 B	¥ 626 M
R&D expenses	-	-
Income taxes	¥ 475 M	¥ 565 M
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Cash flow statement
Operating CF	-	¥ 3 B
Investment CF	-	¥ -371 M
Financial CF	-	¥ -716 M
Foreign Exchange Effects	-	¥ 1 M
Net Change in Cash	-	¥ 2 B
Free CF	-	¥ 2 B
Capital expenditures	-	¥ -2 M
Cash dividends paid	-	¥ -629 M
Repayment loans	-	-
Indicator	メディパル HLDGS (2013-03-31)	NICHIDEN (2013-03-31)
Shareowners' equity
Issuance of new shares	-	-
Dividends from surplus	¥ -3 B	¥ -629 M
Net income	¥ 5 B	¥ 556 M
Purchase of treasury stock	¥ -5 B	¥ -4 M
Other Change in Stockholders Equity	¥ -55 B	-
Other Change in Net Assets	¥ 1 B	¥ 772 M
Net Change in Net Assets	¥ -57 B	¥ 695 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: メディパル HLDGS  NICHIDEN 

Statement Type

Annual : メディパルホールディングス+NICHIDEN

First quarter : メディパルホールディングス+NICHIDEN

Second quarter : メディパルホールディングス+NICHIDEN

Third quarter : メディパルホールディングス+NICHIDEN

Analysis Menu

Outline : メディパルホールディングス+NICHIDEN

Statement : メディパルホールディングス+NICHIDEN

Rating : メディパルホールディングス+NICHIDEN

Indicator : メディパルホールディングス+NICHIDEN

Download : メディパルホールディングス+NICHIDEN

Industry Comparison Ranking

Wholesale Trade - EDIUNET Industry Rankings

Wholesale Trade - EDIUNET Credit Rating

Wholesale Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo中央区 - EDIUNET Prefectures

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	リーバイ・ストラウス　..	C	2013-11-30
1/20	TIEMCO	BB	2013-11-30
1/15	イワキ	BBB	2013-11-30
1/15	マルカキカイ	BBB	2013-11-30
1/15	ALTECH	BB	2013-11-30
1/15	Shinwa	BBB	2013-11-30 (Q1)
1/15	ONWARD HOLDINGS	A	2013-11-30 (Q3)
1/15	ガリバーインターナショ..	BBB	2013-11-30 (Q3)
1/15	Morito	A	2013-11-30
1/15	BIKE O	BB→BBB	2013-11-30

EDIUNET Investment News (Wholesale Trade)

1/20 Wholesale Trade (リーバイ・..

1/15 Wholesale Trade (イワキ:BBB ..

1/10 Wholesale Trade (エコーＴＤ:..

1/9 Wholesale Trade (KITAKEI:BBB)

1/8 Wholesale Trade (F&A AQUA HO..

1/7 Wholesale Trade (Wakita:A)

1/6 Wholesale Trade (ADVAN:AA)

12/27 Wholesale Trade (ADVANCE:CC ..

12/26 Wholesale Trade (NAGAILEBEN:..

. Wholesale Trade (OOMITSU CO...

Company Information

Ticker	Market	Industry	Month	report	Rating
メディパルホールディングス	7459	TSE 1st	Wholesale Trade	3	Annual	BBB
NICHIDEN	9902	TSE 1st	Wholesale Trade	3	Annual	AA

Related Company

Wakita (Sales ¥ 48 B)

KONDOTEC (Sales ¥ 41 B)

Tokyo Electron (Sales ¥ 497 B)

OKAYA (Sales ¥ 692 B)

Ryoden Trading (Sales ¥ 203 B)

メディパルホールディングス (Sales ¥ 2.8 T)

Ai Holdings (Sales ¥ 32 B)

ヤナセ (Sales ¥ 337 B)

伊藤忠エネクス (Sales ¥ 1.4 T)

Shinwa (Sales ¥ 33 B)

SIIX (Sales ¥ 190 B)

ドウシシャ (Sales ¥ 99 B)

Ryosan (Sales ¥ 206 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .